Baynes Roy D. sold Natera Inc. ($NTRA) shares on the open market eight times over the past year, totaling $2.8 million, with the latest sale on November 20, 2025. His sales volume ranks 2,836th among 11,678 insiders, below the average of $8.6 million per seller and 6.37 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Eikon Therapeutics, Inc. | $EIKN | Baynes Roy D. | Chief Medical Officer | A | Stock Option (Right to Buy) | 134088 | $0.00 | 134,088.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2026 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 70 | $0.00 | 18,429.0000 | 136,721,000 | 0.38% | 0.00% |
| Nov. 19, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1250 | $213.47 | 22,221.0000 | 137,187,000 | 5.33% | 0.00% |
| Nov. 19, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1727 | $214.79 | 20,494.0000 | 137,187,000 | 7.77% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Stock Option (right to buy) | 7068 | $0.00 | 0.0000 | 137,187,000 | 100.00% | 0.01% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Stock Option (right to buy) | 600 | $0.00 | 0.0000 | 137,187,000 | 100.00% | 0.00% |
| Nov. 19, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Stock Option (right to buy) | 5112 | $0.00 | 600.0000 | 137,187,000 | 89.50% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1884 | $224.89 | 18,359.0000 | 137,187,000 | 9.31% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1900 | $223.90 | 20,243.0000 | 137,187,000 | 8.58% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1800 | $222.90 | 22,143.0000 | 137,187,000 | 7.52% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 900 | $221.81 | 23,943.0000 | 137,187,000 | 3.62% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1184 | $220.14 | 24,843.0000 | 137,187,000 | 4.55% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Common Stock | 7068 | $41.19 | 26,027.0000 | 137,187,000 | 37.28% | 0.01% |
| Nov. 19, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 2135 | $216.07 | 18,359.0000 | 137,187,000 | 10.42% | 0.00% |
| Nov. 20, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Common Stock | 600 | $40.93 | 18,959.0000 | 137,187,000 | 3.27% | 0.00% |
| Nov. 19, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Common Stock | 5112 | $40.93 | 23,471.0000 | 137,187,000 | 27.84% | 0.00% |
| Oct. 31, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 93 | $0.00 | 18,359.0000 | 137,187,000 | 0.51% | 0.00% |
| July 25, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 108 | $0.00 | 18,266.0000 | 136,388,000 | 0.59% | 0.00% |
| June 27, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 2143 | $0.00 | 18,158.0000 | 134,750,000 | 13.38% | 0.00% |
| June 11, 2025 | Aardvark Therapeutics, Inc. | $AARD | Baynes Roy D. | Not found | A | Stock Option (right to buy) | 30508 | $0.00 | 30,508.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2025 | Nurix Therapeutics, Inc. | $NRIX | Baynes Roy D. | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 75,886,817 | 9999.99% | 0.03% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | A | Common Stock | 6500 | $0.00 | 37,500.0000 | 78,888,861 | 20.97% | 0.01% |
| April 25, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 116 | $0.00 | 16,015.0000 | 134,750,000 | 0.73% | 0.00% |
| March 11, 2025 | Nurix Therapeutics, Inc. | $NRIX | Baynes Roy D. | Director | A | Director Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 75,886,817 | 9999.99% | 0.07% |
| Feb. 6, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | M | Stock option (right to buy) | 10000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 6, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | M | Common Stock | 10000 | $17.44 | 41,000.0000 | 78,888,861 | 32.26% | 0.01% |
| Feb. 6, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | S | Common Stock | 10000 | $22.00 | 31,000.0000 | 78,888,861 | 24.39% | 0.01% |
| Jan. 31, 2025 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 92 | $0.00 | 15,899.0000 | 124,718,000 | 0.58% | 0.00% |
| Jan. 23, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | M | Common Stock | 16000 | $17.50 | 47,000.0000 | 78,888,861 | 51.61% | 0.02% |
| Jan. 23, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | S | Common Stock | 16000 | $20.00 | 31,000.0000 | 78,888,861 | 34.04% | 0.02% |
| Jan. 23, 2025 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | M | Stock option (right to buy) | 16000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.02% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Common Stock | 22000 | $22.83 | 37,807.0000 | 123,775,000 | 139.18% | 0.02% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1983 | $149.98 | 15,807.0000 | 123,775,000 | 11.15% | 0.00% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 2106 | $148.74 | 17,790.0000 | 123,775,000 | 10.59% | 0.00% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 9467 | $147.31 | 19,896.0000 | 123,775,000 | 32.24% | 0.01% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 1770 | $146.26 | 29,363.0000 | 123,775,000 | 5.69% | 0.00% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 16404 | $145.21 | 31,133.0000 | 123,775,000 | 34.51% | 0.01% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | S | Common Stock | 5500 | $144.26 | 47,537.0000 | 123,775,000 | 10.37% | 0.00% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Common Stock | 15230 | $24.42 | 53,037.0000 | 123,775,000 | 40.28% | 0.01% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Stock Option (right to buy) | 15230 | $0.00 | 0.0000 | 123,775,000 | 100.00% | 0.01% |
| Nov. 15, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | M | Stock Option (right to buy) | 22000 | $0.00 | 0.0000 | 123,775,000 | 100.00% | 0.02% |
| Oct. 25, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 124 | $0.00 | 15,807.0000 | 123,775,000 | 0.79% | 0.00% |
| July 26, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 143 | $0.00 | 15,683.0000 | 122,853,000 | 0.92% | 0.00% |
| June 28, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 2964 | $0.00 | 15,540.0000 | 120,814,000 | 23.57% | 0.00% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | A | Common Stock | 6500 | $0.00 | 31,000.0000 | 74,267,418 | 26.53% | 0.01% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Baynes Roy D. | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| April 26, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 169 | $0.00 | 12,576.0000 | 120,814,000 | 1.36% | 0.00% |
| Jan. 26, 2024 | Natera, Inc. | $NTRA | Baynes Roy D. | Not found | A | Common Stock | 215 | $63.79 | 12,407.0000 | 114,997,000 | 1.76% | 0.00% |